Kala Bio (KALA) Other Working Capital Changes (2016 - 2017)
Kala Bio (KALA) posted Other Working Capital Changes of $1.6 million for Q1 2026, up 230.2% sequentially from -$1.2 million in Q4 2025, and down 13.73% YoY from $1.9 million in Q1 2025.
Kala Bio (KALA) Other Working Capital Changes (2016 - 2017) Analysis & Trends
Kala Bio has reported Other Working Capital Changes for 11 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Other Working Capital Changes fell 266.67% year-over-year to -$5000.0 in Q4 2017, while the trailing twelve-month figure through Sep 2018 was -$25000.0 (down 2600.0% YoY) and the FY2017 annual result came in at -$7000.0, up 63.16% from the prior year.
- Other Working Capital Changes rose to -$5000.0 in Q4 2017 per KALA's latest filing, from -$6000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $18000.0 in Q1 2017 and troughed at -$14000.0 in Q2 2017.
- A 5-year average of -$132117.6 and a median of -$461000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 887.65% in 2022, down 1020.93% in 2022.
- Over 2 years, Other Working Capital Changes stood at $3000.0 in 2016, then plunged by 266.67% to -$5000.0 in 2017.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$5000.0, -$6000.0, and -$14000.0 for Q4 2017, Q3 2017, and Q2 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -5,000.00 |
| Dec 31, 2017 | -5,000.00 |
| Dec 31, 2017 | -5,000.00 |
| Sep 30, 2017 | -6,000.00 |
| Sep 30, 2017 | -6,000.00 |
| Sep 30, 2017 | -6,000.00 |
| Jun 30, 2017 | -14,000.00 |
| Jun 30, 2017 | -14,000.00 |
| Jun 30, 2017 | -14,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Dec 31, 2016 | 3,000.00 |
| Dec 31, 2016 | 3,000.00 |
| Dec 31, 2016 | 3,000.00 |
| Sep 30, 2016 | -4,000.00 |
| Sep 30, 2016 | -4,000.00 |
| Sep 30, 2016 | -4,000.00 |